Previously known as RaNA Therapeutics. Translate Bio is a leading biotechnology company focused on pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases. The company’s RNA platforms for powering endogenous therapeutic protein production is applicable to a broad range of diseases including rare diseases of the liver, lung and central nervous system (CNS). For more information about the company, please visit www.translate.bio.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $20.7M
Founded date: 2011
Investors 4
| Date | Name | Website |
| 05.03.2022 | M Ventures | m-ventures... |
| - | Omega Fund... | omegafunds... |
| - | MRL Ventur... | mrlv.com |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.01.2012 | - | $20.7M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 06.08.2021 | Translate Bio Announces Second Quarter 2021 Financial Result... | -- Entered into a definitive agreement under which Sanofi will acquire, subject to customary conditi... | marketscre... |
| 04.08.2021 | Why the IPO markets aren’t quite the dotcom bubble all over ... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 04.08.2021 | Why the IPO markets aren’t quite the dotcom bubble all over ... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 19.04.2021 | TRANSLATE BIO, INC. Translate Bio Announces Key Leadership ... | -- Seasoned healthcare executive, Brendan Smith, appointed as Chief Financial Officer, bringing stra... | marketscre... |
| 19.04.2021 | TRANSLATE BIO, INC. Translate Bio Announces Publication of ... | -- Multiple antigen constructs, including the construct used in MRT5500, induced potent neutralizing... | marketscre... |
| 12.03.2021 | Sanofi and Translate Bio initiate Phase 1/2 clinical trial o... | Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate Clinic... | globenewsw... |
| 18.02.2021 | Translate Bio to Present at the SVB Leerink Virtual 10th Ann... | LEXINGTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage m... | globenewsw... |
| 16.04.2020 | Covid-19 vaccine tracker updated to include GSK/Sanofi ... | By Jeff Craven Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the ... | endpts.com... |
| 09.04.2020 | Covid-19 Tracker updates vaccine candidates | By Jeff Craven On March 11, the World Health Organization classified the Covid-19 outbreak as... | endpts.com... |
| 28.06.2018 | Term Sheet — Thursday, June 28 | LYFTED Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From Extra... | fortune.co... |
Show more